You have 9 free searches left this month | for more free features.

Condition

Prostate Cancer (1)

Prostatic Neoplasms (1)

Overall Status

Active, not recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 3 (2)

Sponsor

Aragon Pharmaceuticals, Inc. (1)

Chinese University of Hong Kong (1)

Collaborator

Janssen, LP (1)

Intervention

apalutamide (2)

abiraterone acetate (1)

enzalutamide (1)

placebo (1)

prednisone (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

JN56021927

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Prostatic Tumors Trial in Worldwide (Apalutamide, Abiraterone acetate, Prednisone)

Active, not recruiting

Prostatic Neoplasms

Apalutamide
+3 more

Phoenix, Arizona
+183 more

Jan 17, 2023

Prostate Cancer Trial in Shatin (Apalutamide, Enzalutamide)

Recruiting

Prostate Cancer

Shatin, Hong Kong

Prince of Wales Hospital

Aug 3, 2021